Dysfunctional high-density lipoprotein: not only quantity but first of all quality?

被引：8
|
作者：
Agouridis, Aris P. [1 ,2 ]
Banach, Maciej [3 ]
Mikhailidis, Dimitri P. [4 ]
机构：
[1] Univ Ioannina, Sch Med, Dept Internal Med, GR-45110 Ioannina, Greece
[2] Royal Free London Fdn Trust, Dept Clin Biochem, Vasc Dis Prevent Clin, London, England
[3] Med Univ Lodz, Chair Nephrol & Hypertens, Dept Hypertens, Lodz, Poland
[4] UCL, Dept Clin Biochem, Vasc Dis Prevent Clin, Sch Med, London NW3 2QG, England
来源：
ARCHIVES OF MEDICAL SCIENCE | 2015年 / 11卷 / 01期
关键词：
HDL; SUBPOPULATIONS; CHOLESTEROL; DRUGS;
D O I：
10.5114/aoms.2015.49816
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：230 / 231
页数：2
相关论文
共 50 条
  • [1] High-density lipoprotein: quantity or quality?
    Tziomalos, Konstantinos
    JOURNAL OF THORACIC DISEASE, 2016, 8 (11) : 2975 - 2977
  • [2] Dysfunctional high-density lipoprotein
    Feng, Hong
    Li, Xiang-An
    CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2009, 16 (02) : 156 - 162
  • [3] High-Density Lipoprotein Quantity or Quality for Cardiovascular Prevention?
    Calabresi, Laura
    Gomaraschi, Monica
    Franceschini, Guido
    CURRENT PHARMACEUTICAL DESIGN, 2010, 16 (13) : 1494 - 1503
  • [4] The paradox of dysfunctional high-density lipoprotein
    Ansell, Benjamin J.
    Fonarow, Gregg C.
    Fogelman, Alan M.
    CURRENT OPINION IN LIPIDOLOGY, 2007, 18 (04) : 427 - 434
  • [5] Dysfunctional High-Density Lipoprotein and Atherosclerosis
    Shawn Ragbir
    John A. Farmer
    Current Atherosclerosis Reports, 2010, 12 : 343 - 348
  • [6] Dysfunctional High-Density Lipoprotein and Atherosclerosis
    Ragbir, Shawn
    Farmer, John A.
    CURRENT ATHEROSCLEROSIS REPORTS, 2010, 12 (05) : 343 - 348
  • [7] MEASURES OF HIGH-DENSITY LIPOPROTEIN QUANTITY AND QUALITY PREDICT CARDIOVASCULAR OUTCOME AT ALL LEVELS OF MYELOPEROXIDASE
    Nicholls, Stephen J.
    Tang, Wai Hong Wilson
    Brennan, Danielle M.
    Hazen, Stanley L.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (10)
  • [8] High-density lipoprotein is a nanoparticle, but not all nanoparticles are high-density lipoprotein
    Cormode, David P.
    Fisher, Edward A.
    Stroes, Erik S. G.
    Mulder, Willem J. M.
    Fayad, Zahi A.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (38) : E3548 - E3548
  • [9] Formation of dysfunctional high-density lipoprotein by myeloperoxidase
    Nicholls, SJ
    Zheng, LM
    Hazen, SL
    TRENDS IN CARDIOVASCULAR MEDICINE, 2005, 15 (06) : 212 - 219
  • [10] Myeloperoxidase, inflammation, and dysfunctional high-density lipoprotein
    Smith, Jonathan D.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2010, 4 (05) : 382 - 388
12345